We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
European Union, United Kingdom - May 21 2012
We comment below on two of the main new stories in the life sciences area last week; the renewed focus on medicines shortages highlighted by the All Parties Pharmacy Group (APPG) Report and the Advocate-General’s opinion on AstraZeneca’s Losec appeal.
United Kingdom - March 1 2012
There have been two recent English High Court decisions in the long-running dispute involving the legality of British publicans buying decoder boxes and cards from outside the UK to show live English Premier League football matches more cheaply than buying decoders from the UK.
United Kingdom - December 15 2011
A new service for litigating intellectual property (IP) rights owned by small and medium sized businesses (SMEs) is to be introduced at the Patents County Court (PCC) by the end of 2012.
European Union - July 5 2011
The Council of the European Union has formally adopted the Falsified Medicines Directive ("the Directive") which had been approved by the European Parliament in February 2011.
Canada, United Kingdom - April 14 2011
The award of £17.5 million damages to Apotex under a cross-undertaking in damages given by Servier has been set aside by the High Court on the basis of public policy and the rule of law that no action can arise from an illegal or immoral act – here the manufacture of a generic medicine that infringed a valid foreign patent.
